N. Shao et al. / Tetrahedron xxx (2018) 1e7
5
4.2.7. 1-(5-(3-Methoxybenzoyl)-6-(3-methoxyphenyl)indolizin-7-
yl)-1H-pyrrole-2-carbaldehyde (2g)
s), 7.57 (2H, dt, J ¼ 8.5, 1.5 Hz), 7.48 (2H, tt, J ¼ 8.5, 1.0 Hz), 7.42 (1H,
tt, J ¼ 8.5, 1.5 Hz), 7.21 (1H, dd, J ¼ 2.5, 1.0 Hz), 7.16 (1H, ddd, J ¼ 4.0,
1.5, 1.0 Hz), 6.61 (1H, dd, J ¼ 4.0, 2.5 Hz); 13C NMR (125 MHz,
Following the general procedure, 1-(2-(3-methoxyphenyl)-2-
oxoethyl)-1H-pyrrole-2-carbaldehyde 1a-7 (48.6 mg, 0.2 mmol)
was used. Purification via column chromatography on silica gel
(hexate:EtOAc ¼ 15:1, Rf ¼ 0.5) afforded 2g as yellow solid (28.1 mg,
DMSO):
d 156.8, 138.6, 129.8, 127.0, 126.3, 123.3, 120.0, 112.6, 109.4,
105.6; HRMS Calcd. for C13H10N2O þ Hþ: 211.0871, found: 211.0873.
60% yield). Mp: 115e117 ꢀC. 1H NMR (500 MHz, CDCl3):
d
9.40 (1H,
4.3.2. 3-(p-Tolyl)pyrrolo[1,2-a]pyrazin-1(2H)-one (3b)
s), 7.54 (1H, s), 7.33 (2H, dt, J ¼ 8.5, 0.5 Hz), 7.22 (2H, m), 7.03 (1H,
ddd, J ¼ 8.5, 3.0, 1.0 Hz), 6.86 (4H, m), 6.67 (1H, dd, J ¼ 4.0, 1.0 Hz),
6.56 (1H, ddd, J ¼ 8.5, 2.5, 0.5 Hz), 6.52 (1H, dt, J ¼ 7.5, 1.0 Hz), 6.42
(1H, t, J ¼ 0.5 Hz), 6.21 (1H, dd, J ¼ 4.0, 3.0 Hz), 3.78 (3H, s), 3.50 (3H,
Following the general procedure, 1-(2-oxo-2-(p-tolyl)ethyl)-1H-
pyrrole-2-carbonitrile 1b-2 (44.8 mg, 0.2 mmol) was used. Purifi-
cation
(CHCl3:CH3OH ¼ 20:1, Rf ¼ 0.7) afforded 3b as white solid (40.8 mg,
91% yield). Mp: 189e191 ꢀC. 1H NMR (500 MHz, DMSO):
10.74 (1H,
via
column
chromatography
on
silica
gel
s); 13C NMR (125 MHz, CDCl3):
d
191.0, 178.2, 170.7, 159.3, 158.2,
d
136.7, 133.6, 133.1, 131.6, 131.1, 131.1, 129.4, 128.3, 128.3, 122.2, 122.2,
122.1, 120.8, 117.8, 115.4, 114.1, 113.0, 112.3, 110.1, 101.7, 55.0, 54.5;
HRMS Calcd. for C28H22N2O4 þ Hþ: 451.1658, found: 451.1655.
s), 7.70 (1H, s), 7.56 (2H, d, J ¼ 8.0 Hz), 7.50 (1H, dd, J ¼ 2.5, 1.5 Hz),
7.26 (2H, d, J ¼ 8.0 Hz), 6.90 (1H, dd, J ¼ 4.0, 2.0 Hz), 6.56 (1H, dd,
J ¼ 3.5, 2.5 Hz), 2.34 (3H, s); 13C NMR (125 MHz, DMSO):
d 156.8,
138.6, 129.8, 127.0, 126.3, 123.3, 120.0, 112.6, 109.4, 105.6, 21.2;
4.2.8. 1-(5-(Furan-2-carbonyl)-6-(furan-2-yl)indolizin-7-yl)-1H-
pyrrole-2-carbaldehyde (2h)
HRMS Calcd. for C14H12N2O þ Hþ: 225.1028, found: 225.1036.
Following the general procedure, 1-(2-(furan-2-yl)-2-oxoethyl)-
1H-pyrrole-2-carbaldehyde 1a-8 (40.6 mg, 0.2 mmol) was used.
Purification via column chromatography on silica gel (hex-
ane:EtOAc ¼ 15:1, Rf ¼ 0.5) afforded 2h as yellow solid (27.2 mg,
4.3.3. 3-(4-Methoxyphenyl)pyrrolo[1,2-a]pyrazin-1(2H)-one (3c)
Following the general procedure, 1-(2-(4-methoxyphenyl)-2-
oxoethyl)-1H-pyrrole-2-carbonitrile 1b-3 (48.0 mg, 0.2 mmol) was
used. Purification via column chromatography on silica gel
(CHCl3:CH3OH ¼ 20:1, Rf ¼ 0.7) afforded 3c as white solid (42.7 mg,
70% yield). Mp: 114e116 ꢀC. 1H NMR (500 MHz, CDCl3):
d 9.50 (1H,
s), 7.57 (1H, d, J ¼ 1.0 Hz), 7.51 (1H, s), 7.50 (1H, dd, J ¼ 2.5, 1.0 Hz),
7.07 (2H, dd, J ¼ 3.0, 0.5 Hz), 7.03 (1H, dd, J ¼ 4.0, 1.5 Hz), 6.94 (1H,
m), 6.89 (1H, d, J ¼ 4.0, 2.0 Hz), 6.66 (1H, dd, J ¼ 4.0, 1.0 Hz), 6.39
(1H, dd, J ¼ 3.5, 1.5 Hz), 6.33 (1H, dd, J ¼ 4.0, 2.5 Hz), 6.06 (1H, dd,
J ¼ 4.0, 1.5 Hz), 5.72 (1H, d, J ¼ 3.5 Hz); 13C NMR (125 MHz, CDCl3):
89% yield). Mp: 200e202 ꢀC. 1H NMR (500 MHz, DMSO):
d 10.72
(1H, s), 7.64 (1H, s), 7.60 (2H, dd, J ¼ 6.5, 2.0 Hz), 7.43 (1H, dd, J ¼ 2.5,
1.5 Hz), 7.02 (2H, dd, J ¼ 7.0, 2.0 Hz), 6.89 (1H, dd, J ¼ 4.0, 1.0 Hz),
6.56 (1H, dd, J ¼ 4.0, 2.5 Hz), 3.34 (3H, s); 13C NMR (125 MHz,
DMSO):
d 160.1, 156.8, 127.8, 126.9, 124.9, 123.2, 119.9, 114.6, 112.5,
d
178.6, 177.8, 151.7, 148.6, 145.8, 143.3, 133.8, 131.6, 131.3, 130.3,
109.3, 105.1, 55.7; HRMS Calcd. for C14H12N2O2 þ Hþ: 241.0977,
127.1, 121.9, 121.5, 119.5, 116.2, 114.2, 114.1, 112.6, 111.5, 111.2, 110.7,
found: 241.0971.
103.1; HRMS Calcd. for
371.1048.
C
22H14N2O4
þ
Hþ: 371.1032, found:
4.3.4. 3-(4-Fluorophenyl)pyrrolo[1,2-a]pyrazin-1(2H)-one (3d)
Following the general procedure, 1-(2-(4-fluorophenyl)-2-
oxoethyl)-1H-pyrrole-2-carbonitrile 1b-4 (45.6 mg, 0.2 mmol) was
used. Purification via column chromatography on silica gel
(CHCl3:CH3OH ¼ 20:1, Rf ¼ 0.7) afforded 3d as white solid (43.3 mg,
95% yield). Mp: 205e207 ꢀC. 1H NMR (500 MHz, DMSO):
4.2.9. 1-(6-(Thiophen-2-yl)-5-(thiophene-2-carbonyl)indolizin-7-
yl)-1H-pyrrole-2-carbaldehyde (2i)
Following the general procedure, 1-(2-oxo-2-(thiophen-2-yl)
ethyl)-1H-pyrrole-2-carbaldehyde 1a-9 (43.8 mg, 0.2 mmol) was
used. Purification via column chromatography on silica gel (hex-
ane:EtOAc ¼ 15:1, Rf ¼ 0.5) afforded 2i as yellow solid (32.8 mg, 78%
d
10.82(1H, s), 7.71 (3H, m), 7.45 (1H, dd, J ¼ 2.5, 1.5 Hz), 7.30 (2H, t,
J ¼ 9.0 Hz), 6.91 (1H, dd, J ¼ 3.0, 1.0 Hz), 6.57 (1H, dd, J ¼ 4.0, 2.5 Hz);
13C NMR (125 MHz, DMSO):
yield). Mp: 118e120 ꢀC. 1H NMR (500 MHz, CDCl3):
d
9.48 (1H, s),
d
162.7 (d, J ¼ 244.5 Hz), 156.8, 129.1 (d,
7.65 (1H, dd, J ¼ 5.0, 1.0 Hz), 7.55 (1H, d, J ¼ 2.0 Hz), 7.52 (1H, s), 7.34
(1H, m), 7.07 (1H, dd, J ¼ 5.5, 1.5 Hz), 6.97 (1H, dd, J ¼ 5.0, 4.0 Hz),
6.95 (1H, d, J ¼ 4.0, 1.5 Hz), 6.89 (2H, dd, J ¼ 4.0, 3.0 Hz), 6.78 (1H,
dd, J ¼ 3.5, 1.0 Hz), 6.68 (1H, dd, J ¼ 5.0, 3.5 Hz), 6.67 (1H, dd, J ¼ 4.0,
1.5 Hz), 6.27 (1H, d, J ¼ 4.0, 3.0 Hz); 13C NMR (125 MHz, CDCl3):
J ¼ 3.3 Hz), 128.7 (d, J ¼ 8.3 Hz), 126.2, 123.3, 120.2, 116.1 (d,
J ¼ 21.8 Hz), 112.7, 109.5, 106.2; HRMS Calcd. for C13H9FN2O þ Hþ:
229.0777, found: 229.0771.
4.3.5. 3-(4-Chlorophenyl)pyrrolo[1,2-a]pyrazin-1(2H)-one (3e)
Following the general procedure, 1-(2-(4-chlorophenyl)-2-
oxoethyl)-1H-pyrrole-2-carbonitrile 1b-5 (48.8 mg, 0.2 mmol) was
used. Purification via column chromatography on silica gel
(CHCl3:CH3OH ¼ 20:1, Rf ¼ 0.7) afforded 3e as white solid (45.9 mg,
d
183.4, 178.7, 142.7, 136.5, 136.0, 134.1, 133.6, 132.1, 132.0, 131.5,
130.4, 128.4, 128.3, 126.4, 118.6, 116.1, 115.9, 113.8, 110.7, 102.7;
HRMS Calcd. for C22H14N2O2S2 þ Hþ: 403.0575, found: 403.0572.
4.3. General procedure for systhesis of 3
94% yield). Mp: 226e227 ꢀC. 1H NMR (500 MHz, DMSO):
d 10.72
(1H, s), 7.78 (1H, s), 7.69 (2H, m), 7.52 (2H, d, J ¼ 9.0 Hz), 7.46 (1H,
A mixture of N-substituted pyrrole-2-carbonitrile 1b (0.2 mmol,
1.0 equiv.), t-BuOK (0.24 mmol, 1.2 equiv.) was stirred in 2.0 mL
toluene at 80 ꢀC. After being stirred for 12 h, CHCl3 (4.0 mL) was
added to the mixture and the filtrate was concentrated under
reduced pressure. The residue was purified by column chroma-
tography on silica gel (CHCl3:CH3OH ¼ 20:1) to provide the desired
product 3.
dd, J ¼ 2.5, 1.5 Hz), 6.92 (1H, dd, J ¼ 3.5, 0.5 Hz), 6.58 (1H, dd, J ¼ 4.0,
2.5 Hz); 13C NMR (125 MHz, DMSO):
d 156.7, 133.7, 131.5, 129.2,
128.2, 126.0, 123.3, 120.3, 112.8, 109.6, 106.6; HRMS Calcd. for
C
13H9ClN2O þ Hþ: 245.0482, found: 245.0473.
4.3.6. 3-(4-Bromophenyl)pyrrolo[1,2-a]pyrazin-1(2H)-one (3f)
Following the general procedure, 1-(2-(4-bromophenyl)-2-
oxoethyl)-1H-pyrrole-2-carbonitrile 1b-6 (57.6 mg, 0.2 mmol) was
used. Purification via column chromatography on silica gel
(CHCl3:CH3OH ¼ 20:1, Rf ¼ 0.7) afforded 3f as white solid (53.0 mg,
4.3.1. 3-Phenylpyrrolo[1,2-a]pyrazin-1(2H)-one (3a)
Following the general procedure, 1-(2-oxo-2-(p-tolyl)ethyl)-1H-
pyrrole-2-carbonitrile 1b-1 (42.0 mg, 0.2 mmol) was used. Purifi-
92% yield). Mp: 235e236 ꢀC. 1H NMR (500 MHz, DMSO):
d 10.84
cation
(CHCl3:CH3OH ¼ 20:1, Rf ¼ 0.7) afforded 3a as white solid (41.2 mg,
98% yield). Mp: 151e153 ꢀC. 1H NMR (500 MHz, DMSO):
9.05 (1H,
via
column
chromatography
on
silica
gel
(1H, s), 7.79 (1H, s), 7.64 (4H, m), 7.46 (1H, dd, J ¼ 2.5, 1.5 Hz), 6.92
(1H, dd, J ¼ 4.0, 1.0 Hz), 6.59 (1H, dd, J ¼ 4.0, 2.5 Hz); 13C NMR
d
(125 MHz, DMSO): d 156.7, 132.1, 131.9, 128.5, 126.0, 123.3, 122.2,
Please cite this article in press as: N. Shao, et al., Functionalized N-containing heterocyclic scaffolds derived from N-substituted pyrroles via